摘要
目的：研究急性心肌梗死（AMI）病人发生心力衰竭时应用倍他乐克治疗的临床观察。方法：2004年3月～2006年5月份我院心血管内科病房急性心肌梗死心力衰竭病人52例，其中28例病人应用倍他乐克治疗，另24例未应用倍他乐克及其它β-受体阻滞剂，疗程4周。比较两组心律失常和猝死发生率。结果：治疗组恶性心律失常和心源性猝死的发生率显著低于对照组（P〈0．05），住院期间总死亡率均较对照组有较明显下降，心衰的加重率低于对照组，无1例因服用倍他乐克而出现心动过缓。结论：AMI心力衰竭病人早期口服小剂量倍他乐克较为安全，疗效明显，心电稳定性提高，可使恶性心律失常和心源性猝死的发生率显著降低。
Objective：To know the effect of those treated with Betaloe who are under heart failure after acute myocardial infarction. Methods： We chose 52 cases from Cardiac Internal Department of Inner Mongolia Autonomous Region Hospital from March 2004 to May 2006. 28 cases of them were treated by Betaloc for four weeks. However, others were not treated by any medicine. We compared with the rate o[ arrhythmia and sudden cardiac death. Results： In the therapeutic group, the rate of cardiac arrhythmia and sudden cardiac death was much lower than that of the control group （P （0.05）. The total late of death of therapeutic group in hospital descended remarkably than that of the control group, and the rate of aggravation of heart failure of therapeutic group was lower than that of the control group. No one appeared bradycardia after using Betaloc. Conclusion：It is safe to treat patients with acute heart failure after acute myocardial infarction with small dose of Betaloc in the early period, and the effect is remarkable. Taking small dose of Betaloc in them can improve the electro cardio- stability and cut clown the rate of severe cardiac arrhythmia and sudden cardiac death.
出处
《内蒙古医学杂志》
2009年第3期285-287,共3页
Inner Mongolia Medical Journal
关键词
急性心肌梗死
心力衰竭
倍他乐克
Acute myocardial infarction
Heart failure
Betaloc
